ArticleJournal of materials science. Materials in medicine2026
Controlled drug release and electroconductive performance of 3D printed scaffolds for neural tissue regeneration.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nerve cell repair is a complex process influenced by genetic factors, damage severity, and treatment type. Although nerve tissue engineering has advanced, many scaffolds still fail to mimic the natural electrical properties of nerve tissue or deliver drugs effectively. To address these issues, this study presents a multifunctional scaffold designed to support nerve regeneration while reducing inflammation and pain. The scaffold was fabricated using 3D microextrusion printing, allowing precise control over geometry and composition. Polyvinyl alcohol (PVA) and collagen (Col) provided biocompatibility and biodegradability, while reduced graphene oxide (rGO) enhanced electrical conductivity. Amoxicillin (Amox) and ibuprofen (Ibu) were incorporated for antibacterial and anti-inflammatory effects. The scaffold exhibited a conductivity of (5.83 ± 0.65) × 10⁻³ S/m, and sustained drug release, with amoxicillin reaching ~0.6 mg/L and ibuprofen ~0.12 mg/L after 480 min. It showed strong antibacterial activity, with inhibition zones of 28.3 ± 3.32 mm (E. coli) and 18.34 ± 2.83 mm (S. aureus). Mechanically, it withstood ~5.5 MPa of stress and over 150% tensile strain. Cell viability exceeded 120%, indicating excellent biocompatibility. These results suggest the scaffold effectively integrates conductivity, structural strength, and therapeutic delivery to promote nerve regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.